论文部分内容阅读
应用第二代抗─ＨＣＶ酶免疫试验检测了１９４例各型乙型肝炎患者血清丙型肝炎病毒抗体（抗─ＨＣＶ），结果抗─ＨＣＶ阳性率为２３．２％，其中，重型肝炎（ＳＨ）者为４４．４％、原发性肝癌（ＰＨＣ）者为３７．５％、肝硬化（ＣＩＲ）者为３６．６％、慢活肝（ＣＡＨ）者为２６．１％、慢迁肝（ＣＰＨ）者为１６．７％、急性肝炎（ＡＨ）者为７．１％、无症状ＨＢｓＡｇ携带者（ＡＳＣ）的为６．７％，提示肝病越严重，其抗─ＨＣＶ的阳性率就越高。还发现重叠感染ＨＣＶ的乙型肝炎患者之ＨＢＶ复制率较低。
The second generation anti-HCV enzyme immunoassay was used to detect serum hepatitis C virus antibody (anti-HCV) in 194 patients with various types of hepatitis B. The results showed that the positive rate of anti-HCV was 23.2%. Among them, severe hepatitis ) Were 44.4%, 37.5% in patients with primary liver cancer (PHC), 36.6% in patients with cirrhosis (CIR), 26.1% in patients with slow-acting liver (CAH) (CPH) was 16.7%, acute hepatitis (AH) was 7.1%, asymptomatic HBsAg carriers (ASC) was 6.7%, suggesting that the more severe liver disease, its anti-HCV positive rate The higher. HBV replication was also found to be lower in patients with hepatitis B co-infected with HCV.